PositiveID Corp. (PSID) Finalizes Development of Glucose Measuring System
PositiveID Corp., a developer of unique medical devices and molecular diagnostic systems primarily for diabetes management, today announced it has finalized its first-in-class development of a fully synthetic glucose sensing system to measure glucose levels within the body for people with diabetes. Through collaborative development efforts, PositiveID and its partner RECEPTORS LLC said they believe they have developed the first fully synthetic, stable, sensitive, selective sensing system that is responsive to glucose in human plasma, marking a critical step toward developing an artificial pancreas. "The development of a fully implantable glucose sensor is one of the essential requirements for the…